XML 57 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of the Business - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Candidate
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Number of novel therapeutic oncology candidates 6
Unrestricted cash and cash equivalents and available-for-sale securities $ 124.2